Tomislav Letilović
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tomislav Letilović has a total of 104 co-authors. Here are the top co-authors by number of shared publications:
- Darko Počanić19 shared publications
- Damir Kozmar17 shared publications
- Helena Jerkić
Division of Cardiology, University Hospital Merkur
15 shared publications - Ivica Premužić Meštrović
Department of Pharmacology, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia
14 shared publications - Mario Stipinović13 shared publications
- Stjepan Kranjcevic12 shared publications
Latest Publications
- 1 November 2026
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 21 (11-12) , 232
Baby, you make my heart stop
- 1 November 2026
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 21 (11-12) , 232
Baby, you make my heart stop
- 1 November 2026
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 21 (11-12) , 211
Admission LDL Cholesterol and Short-Term Outcomes in Acute Coronary Syndrome: A Single-Centre Descriptive Study
- 1 November 2026
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 21 (11-12) , 211
Admission LDL Cholesterol and Short-Term Outcomes in Acute Coronary Syndrome: A Single-Centre Descriptive Study
- 1 November 2026
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 21 (11-12) , 221-222
Cardioneuroablation: A Promising Alternative to Permanent Pacemaker Implantation or a Future Standard of Care? A Case Report
- 1 November 2026
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 21 (11-12) , 221-222
Cardioneuroablation: A Promising Alternative to Permanent Pacemaker Implantation or a Future Standard of Care? A Case Report
- 1 March 2025
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 20 (1-2) , 12
A data-driven journey through cardiac surgery referrals at University Hospital “Merkur”
- 1 March 2025
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 20 (1-2) , 12
A data-driven journey through cardiac surgery referrals at University Hospital “Merkur”
- 1 November 2024
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 19 (11-12) , 477
Clinical characteristics of patients treated with debulking techniques during percutaneous coronary intervention
- 1 November 2024
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 19 (11-12) , 477
Clinical characteristics of patients treated with debulking techniques during percutaneous coronary intervention
- 1 November 2024
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 19 (11-12) , 511
General and cardiovascular mortality of Croatian olympic athletes
- 1 November 2024
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 19 (11-12) , 511
General and cardiovascular mortality of Croatian olympic athletes
- 1 November 2024
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 19 (11-12) , 432
Sodium glucose co-transporter 2 inhibitors as early therapy in patients with newly diagnosed heart failure with reduced ejection fraction: real world experience
- 1 November 2024
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 19 (11-12) , 432
Sodium glucose co-transporter 2 inhibitors as early therapy in patients with newly diagnosed heart failure with reduced ejection fraction: real world experience
- 1 November 2022
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 17 (9-10) , 288-289
Cardiac emergencies in the emergency department after the 2020 earthquake – Croatian experiences
- 1 November 2022
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 17 (9-10) , 288-289
Cardiac emergencies in the emergency department after the 2020 earthquake – Croatian experiences
- Open Access
- 1 November 2022
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 17 (9-10) , 177
Psychopharmacotherapy in patients treated at the Department of Electrophysiology, “Merkur” University Hospital
- 1 November 2022
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 17 (9-10) , 177
Open AccessPsychopharmacotherapy in patients treated at the Department of Electrophysiology, “Merkur” University Hospital
- 4 May 2022
- Published by Taylor & Francis in Acta Clinica Belgica
- Vol. 77 (3) , 565-570
Patients with dementia and atrial fibrillation less frequently receive direct oral anticoagulants (DOACs) and experience higher thrombotic and mortality risk
Objective: To investigate differences in clinical presentation, anticoagulation pattern and outcomes in patients with dementia and atrial fibrillation (AF). Methods: A total of 1217 hospitalized patients with non-valvular AF from two institutions were retrospectively evaluated. Diagnosis of dementia was established by a psychiatrist or a neurologist prior to or during hospitalization. Adequacy of warfarin anticoagulation was assessed during follow-up using at least 10 standardized international ratio values. In addition to unmatched comparison, nested case-control study was performed to further evaluate differences in clinical outcomes between patients with and without dementia. Results: A total of 162/1217 (13.3%) patients were diagnosed with dementia. Among other associations, patients with dementia were significantly older with higher number of comorbidities, had lower estimated glomerular filtration rate (eGFR) and lower left ventricular ejection fraction (LVEF), (P < 0.05 for all analyses). Patients with dementia were significantly less likely to receive direct oral anticoagulants (DOACs; 27.2% vs 40.3%; P = 0.001) and were significantly more likely to be inadequately anticoagulated with warfarin (38.9% vs 28.6%; P = 0.008) than patients without dementia. After matching based on age, eGFR, LVEF, and CHA(2)DS(2)-VAS(C) patients with dementia were significantly more likely to experience inferior overall survival (HR = 1.8; P = 0.001) and shorter time to thrombosis (HR = 2.3; P = 0.019). Conclusion: Our findings speak in support of increased thrombotic and mortality risks in patients with dementia, possibly due to inadequate anticoagulation and higher number of comorbidities.
- 4 May 2022
- Published by Taylor & Francis in Acta Clinica Belgica
- Vol. 77 (3) , 565-570
Patients with dementia and atrial fibrillation less frequently receive direct oral anticoagulants (DOACs) and experience higher thrombotic and mortality risk
Objective: To investigate differences in clinical presentation, anticoagulation pattern and outcomes in patients with dementia and atrial fibrillation (AF). Methods: A total of 1217 hospitalized patients with non-valvular AF from two institutions were retrospectively evaluated. Diagnosis of dementia was established by a psychiatrist or a neurologist prior to or during hospitalization. Adequacy of warfarin anticoagulation was assessed during follow-up using at least 10 standardized international ratio values. In addition to unmatched comparison, nested case-control study was performed to further evaluate differences in clinical outcomes between patients with and without dementia. Results: A total of 162/1217 (13.3%) patients were diagnosed with dementia. Among other associations, patients with dementia were significantly older with higher number of comorbidities, had lower estimated glomerular filtration rate (eGFR) and lower left ventricular ejection fraction (LVEF), (P < 0.05 for all analyses). Patients with dementia were significantly less likely to receive direct oral anticoagulants (DOACs; 27.2% vs 40.3%; P = 0.001) and were significantly more likely to be inadequately anticoagulated with warfarin (38.9% vs 28.6%; P = 0.008) than patients without dementia. After matching based on age, eGFR, LVEF, and CHA(2)DS(2)-VAS(C) patients with dementia were significantly more likely to experience inferior overall survival (HR = 1.8; P = 0.001) and shorter time to thrombosis (HR = 2.3; P = 0.019). Conclusion: Our findings speak in support of increased thrombotic and mortality risks in patients with dementia, possibly due to inadequate anticoagulation and higher number of comorbidities.